TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06101875

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Coach (Health coaching)
Description: Patients will be assigned a health coach and be eligible to 8 times, 1 hour sessions over a 12 week period. The health coach will use techniques to increase their ability to self-manage, motivation levels and commitment to change their behaviour.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Digital Toolkit (Control)
Description: This is an online website, unsupervised, 12-week self-management programme.
Study: NCT04720820

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early Supported discharge with home based Rehabilitation
Description: Treatment by Physiotherapist and occupational therapist at least 30 minutes each, per week provided at home.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional rehabilitation
Description: Treatment will be provided according to current hospital's stroke rehabilitation program.
Study: NCT06221215

Intervention type: PROCEDURE
Intervention: trauma
Description: The main purpose of this study is to observe whether the early hormone changes and trends in the two groups of patients with or without trauma.
Study: NCT06046859

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Description: Subjects will be randomized to take Fluoxetine (10mg by mouth per day for first 14 days then 20 mg by mouth for 9 months). The randomized drug will be prescribed by the study team on the day of randomization so that the patient may be monitored for side effects during the remainder of their hospitalization. The patient will be prescribed the randomized medication on the day of discharge and a 90 day supply will be provided by the inpatient research pharmacy at the 2 week, 3 month, and 6 month follow-up visits

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: When a patient is enrolled, the inpatient research pharmacy will dispense the appropriately randomized medication in a visually similar, over-encapsulated form as Fluoxetine
Study: NCT06213233

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participant will take placebo days 1-28 during study treatment. Given the pragmatic design, participants will be instructed to take the study drug whenever participants wish, with suggested starting dosing of 0.2 milliliter (mL) in the morning and 0.2mL in the evening (up to 1.2mL per day).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabidiol
Description: Participant will take Epidiolex days 1-28 during study treatment. Given the pragmatic design, participants will be instructed to take the study drug whenever participants wish, with suggested starting dosing of 0.2 milliliter (mL) in the morning and 0.2mL in the evening (up to 1.2mL per day).
Study: NCT05178420

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Statin discontinuation
Description: Statin therapy will be stopped. Additional lipid-lowering medication lowering LDL cholesterol will also be stopped.
Study: NCT06014697

Intervention type: DIAGNOSTIC_TEST
Intervention: Optical Coherence Tomography
Description: Assessment of the lesion with a non-invasive OCT scan according to a confidence scale (5-point Likert scale: 1 Definitely not invasive, 2 Probably not invasive, 3 Unknown invasive or non-invasive, 4 Probably invasive, 5 Definitely invasive)

Intervention type: DIAGNOSTIC_TEST
Intervention: Optical Coherence Tomography
Description: Assessment of the lesion with a non-invasive OCT scan according to a confidence scale (5-point Likert scale: 1 Definitely not invasive, 2 Probably not invasive, 3 Unknown invasive or non-invasive, 4 Probably invasive, 5 Definitely invasive)

Intervention type: OTHER
Intervention: Clinical assessment
Description: Clinical assessment of the lesion by a dermatologist according to a confidence scale (5-point Likert scale: 1 Definitely not invasive, 2 Probably not invasive, 3 Unknown invasive or non-invasive, 4 Probably invasive, 5 Definitely invasive)

Intervention type: OTHER
Intervention: Clinical assessment
Description: Clinical assessment of the lesion by a dermatologist according to a confidence scale (5-point Likert scale: 1 Definitely not invasive, 2 Probably not invasive, 3 Unknown invasive or non-invasive, 4 Probably invasive, 5 Definitely invasive)
Study: NCT05048186

Intervention type: BEHAVIORAL
Intervention: Attention Deficit Hyperactivity Disorder Treatment Decision Aid
Description: The parent pre-visit cards from the Cincinnati Children's Hospital's Attention Deficit Hyperactivity Disorder (ADHD) Treatment for School Age Children Decision Aid were used in this study. The 6 pre-visit cards provide an overview of ADHD treatment options, the respective benefits and downsides of each option, and questions to elicit goals/preferences. The four different treatment options presented were: (1) watchful waiting, (2) behavioral treatment, (3) medication treatment, and (4) combined treatment (behavioral and medication together).
Study: NCT04885257

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Description: Methylphenidate oral pill. Dosing instructions given to

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo arm
Study: NCT05273814

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Tislelizumab intravenous infusion 200mg d4
Study: NCT06119568

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robot assisted laparoscopic Radical/simple nephrectomy (RN), Partial nephrectomy (PN) or Radical Prostatectomy (RP).
Description: Three different surgery interventions: 1. Radical Nephrectomy: Complete remove of the kidney; 2. Partial Nephrectomy: Partial remove of a section in the kidney. 3. Radical Prostatectomy: Complete remote of the prostate gland. During each of these procedures removal of regional lymph nodes (lymphadenectomy) and lysis of abdominal lesions may be performed according to patient medical condition and/or surgeon criteria.
Study: NCT05273814

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Pemetrexed intravenous infusion 500mg/m2 d1

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Pemetrexed intravenous infusion 7.5mg/kg，d1
Study: NCT05681234

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 18F-RD2
Description: Patients will receive 5-10 mCi 18F-RD2
Study: NCT04783025

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Blended Gaming COVID-19 Training System (BGCTS)
Description: BGCTS is a blended training programme integrated with games and short video clips for Residential Care Home staffs to learn the principles of infection control and reinforce actions needed to stop the spread of COVID-19 within the RCHs, and to care for those residents suspected of having COVID-19. The contents of the training will refer to the evidence-based contents from The COVID-19 Risk Communication Package For Healthcare Facilities.~Dosage of the intervention. Staffs are encouraged to learn each topic independently in 15 minutes. It will take a total of 120 minutes to complete all eight topics in 2 weeks. Staffs will attend two 30-minute face-to-face group sessions conducted by research nurse (and the Infection Control Officer of the RCH) to clarify concepts (one per week; after playing the games). Scores and progress bar will be shown to the staff so as a form of motivation to encourage continuous participation in the training.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care, infection control briefing
Description: Participants in the CG will receive usual care, the infection control briefing given by the Infection Control Officer (ICO) of the RCHs to all staffs. Usually the briefing is irregular, non-standardized and determined by ICOs, depending on when the ICOs receive the information about infection control practice from Centre for Health Protection of the Hong Kong government. The format and duration of this briefing is determined by the ICO. Some ICOs deliver the infection control information in the form of posters or a written document, and circulate these materials to all staffs.
Study: NCT05695469

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Smart resuscitation glove (ResuGlove)
Description: Participants will be randomly assigned into two equal groups using the online-based random number generator (https://www.random.org). Participants in the ResuGlove group will perform hand-only CPR wearing the ResuGlove with a running feedback program for 2 minutes.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Smart resuscitation glove (ResuGlove)
Description: Participants will be randomly assigned into two equal groups using the online-based random number generator (https://www.random.org). Participants in the ResuGlove group will perform hand-only CPR wearing the ResuGlove with a running feedback program for 2 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional CPR
Description: Participants in the traditional CPR group will perform hand-only CPR without the ResuGlove and feedback guidance for 2 minutes.
Study: NCT05648006

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: OH2
Description: Oncolytic Type 2 Herpes Simplex Virus

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine
Description: 1000 mg/m2, orally administered twice a day, D1 to D14, repeated every 3 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: 1000 mg/m2, orally administered twice a day, D1 to D14, repeated every 3 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bevacizumab
Description: Bevacizumab: 7.5 mg/kg, intravenously, once every 3 weeks.
Study: NCT05695469

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional CPR
Description: Participants in the traditional CPR group will perform hand-only CPR without the ResuGlove and feedback guidance for 2 minutes.
Study: NCT05395234

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cook Like A Boss Online - virtual week long cooking camp
Description: The original Cook Like A Boss camp style intervention, was based on the Cook-Ed Model (Asher et al., 2020) and underpinned by SLT and ELT (Bandura \& McClelland, 1977; Kolb, 1984). The content was developed to ensure it was age-appropriate in line with the guidelines (Dean et al., 2021a) and included co-creation. The camp was designed to introduce the children to a range of food and skills and to nurture an initial interest in cooking. The adapted online version of the camp included five daily videos of the original chef performing the recipes. Minor adaptions included the removal of cooking pasta from scratch due to equipment concerns, reordering the days, and chef suggestions around alternative equipment/ingredients to use. The five daily videos were: 1) Introduction \& flatbreads; 2) Chicken Chowder; 3) Baking day; 4) Chilli non Carne; 5) Honey Chilli Chicken
Study: NCT06040775

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Theta Burst Transcranial magnetic Stimulation using real MCF-B65 coil
Description: Site of stimulation will be predetermined at Dorsolateral prefrontal cortex of non-dominant side using the BeamF3 method.1 burst will be - 3 pulses at 50 Hz, burst will be set at 5Hz i.e. interburst interval 200ms .~At100% of resting motor threshold of dominant side - 5 trains (each 40sec on and 20 sec off) will be given at each session with a pause of 1 minute in between 2 trains Standard therapy with Applied Behavior Analysis and sensory integration would continue
Study: NCT04986475

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: Music therapy was performed by listening to the ney sound during the non-stress test procedure.
Study: NCT06040775

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham magnetic stimulation using sham MCF-B65 coil
Description: Similar set parameters using a sham coil which simulates sound and tactile effect of real coil but no electromagnetic induction is produced.~Standard therapy with Applied Behavior Analysis and sensory integration would continue
Study: NCT06453252

Intervention type: OTHER
Intervention: we are aiming to develop a Scoring system based on certain variables derived from both groups
Description: We are aiming to develop a Scoring system based on certain variables derived from both group

Intervention type: OTHER
Intervention: we are aiming to develop a Scoring system based on certain variables derived from both groups
Description: We are aiming to develop a Scoring system based on certain variables derived from both group
Study: NCT03468634

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: endoscopy
Description: Oesophageal endoscopy with biopsy

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: endoscopy
Description: Oesophageal endoscopy with biopsy

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: endoscopy
Description: Oesophageal endoscopy with biopsy

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: endoscopy
Description: Oesophageal endoscopy with biopsy

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: endoscopy
Description: Oesophageal endoscopy with biopsy

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: endoscopy
Description: Oesophageal endoscopy with biopsy

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: endoscopy
Description: Oesophageal endoscopy with biopsy

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: endoscopy
Description: Oesophageal endoscopy with biopsy
Study: NCT05119790

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C] BIIB122 ([14C] DNL151)
Description: Oral dose
Study: NCT05246644

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: acetaminophen
Description: we will use IV acetaminophen and an oral placebo or IV placebo and active oral acetaminophen

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: acetaminophen
Description: we will use IV acetaminophen and an oral placebo or IV placebo and active oral acetaminophen
Study: NCT06408987

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: arthroscopically assisted
Description: Arthroscopically-Assisted reduction through anterolateral portal for visualization and other accessory portals for instrumentation to achieve reduction and postoperative immobilization in a hip spica.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: open surgical reduction
Description: Open reduction through a bikini incision anterior approach and postoperative immobilization in a hip spica.
Study: NCT04837690

Intervention type: PROCEDURE
Intervention: UEMR
Description: (1) the colorectal lumen was completed deflated with 500-1000 mL sterile water using a flushing pump; (2) the lesion and 2-3 mm of normal mucosa surrounding the base of the polyp were snared and subsequently resected with an electrosurgical generator
Study: NCT05157971

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given SC, IV or IT

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin Hydrochloride
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mercaptopurine
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: Given IT

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegaspargase
Description: Given IM or IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine Sulfate
Description: Given IV
Study: NCT05546697

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Online- Yoga-based Intervetion
Description: See arms description

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Online- BA
Description: See arms description
Study: NCT04535817

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omalizumab Injection [Xolair]
Description: 300mg via 2 subcutaneous injections every 4 weeks
Study: NCT05030610

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BeatIt-ASD
Description: BeatIt-ASD, designed to be implemented with autistic individuals, is an adaptation of BeatIt. The intervention aims to improve mood and decrease depressive symptoms through an increase in meaningful engagement in recreational, domestic, and social/leisure activities.
Study: NCT06270082

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IK-595
Description: Oral tablet administered in 28-day or 30-day cycles until treatment discontinuation criteria are met.
Study: NCT06320106

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality baseline assessment
Description: They undergo a baseline assessment (including cognitive level and pen and paper tests for visuo-spatial abilities). Then they perform a spatial navigation assessment with an immersive virtual reality application delivered by the Oculus Quest viewer. The spatial navigation application consists of a 5-way star-maze adapted from (Biffi et al 2020 Front. Psychol.) where the participants have to find a treasure hidden at the end of one way. The application measures both the learning of spatial information and the strategy used (egocentric or allocentric).~After the session, the participants fill questionnaires related to cyber-sickness and usability of the application.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality baseline assessment
Description: They undergo a baseline assessment (including cognitive level and pen and paper tests for visuo-spatial abilities). Then they perform a spatial navigation assessment with an immersive virtual reality application delivered by the Oculus Quest viewer. The spatial navigation application consists of a 5-way star-maze adapted from (Biffi et al 2020 Front. Psychol.) where the participants have to find a treasure hidden at the end of one way. The application measures both the learning of spatial information and the strategy used (egocentric or allocentric).~After the session, the participants fill questionnaires related to cyber-sickness and usability of the application.
Study: NCT05308407

Intervention type: OTHER
Group type: OTHER
Intervention: Focus Groups
Description: No intervention involved in this phase of the study

Intervention type: OTHER
Group type: OTHER
Intervention: Pilot randomized controlled trial
Description: The intervention is a virtually delivered, 12 weekly group-based active video game-centered lifestyle physical activity intervention (POWER UP) targeting affect to improve function and quality of life in insufficiently active AYAs with central nervous system tumors.
Study: NCT05941208

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: continuous fascia iliaca compartment block
Description: ultrasound Patients were in supine position and the puncture site was selected at 1 cm below the junction point at 1/3 of the connection of anterior superior spine and pubic tubercle. An ultrasound apparatus (Sonosite) high-frequency probe was placed in parallel to the inguinal fold to distinguish the femoral fascia and fascia iliaca, the needle was inserted with out-of-plane technique at an angle of 45° and the tip of the needle was pointed to the head. Once needle-tip placement under the fascia iliaca by hydrolocation was confirmed, the probe was rotated 90° into a longitudinal parasagittal orientation to visualize the needle tip in-plane and to track cephalad spread of the injectate under fascia iliaca, identification of the fascia iliaca plane through the linear probe and introducing epidural catheter 18 G , continuous infusion of bupivacaine 0.25% by a set rate of 7 ml per hour for 24 hours,
Study: NCT04963036

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Entropy and NOL-Guided Goal Directed Anesthesia
Description: Entropy-guided Anesthesia (Propofol infusion in order to maintain Entropy between 45 and 55) and NOL-guided Analgesia (Remifentanil infusion in order to maintain NOL-Index between 10 and 25).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care Group (Entropy and blinded NOL)
Description: Entropy-guided Anesthesia (Propofol infusion in order to obtain Entropy between 45 and 55) and Remifentanil infusion at the discretion of the anesthetist in charge, based on current practice: patient vitals (Heart Rate, Blood Pressure, Respiratory Rate...), movements, spontaneous breathing, experience....~In this group, nociception monitor screen will be concealed and the NOL index will not be available for guidance of remifentanil dosing).
Study: NCT06173544

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care (SOC)
Description: Participants randomized to this arm will received enhanced standard of care.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adapted Friendship Bench (AFB)
Description: Participants randomized to this arm will receive the Adapted Friendship Bench protocol delivered by a trained counselor.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Friendship Bench (EFB)
Description: Participants randomized to this arm will receive the Enhanced Friendship Bench protocol delivered by a trained counselor and a peer supporter.
Study: NCT05978440

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: onlay preparation
Description: CAD-CAM onlay restorations will be fabricated using rubber dam scanning techniques and evaluated clinically up to 12 months

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: onlay preparation
Description: CAD-CAM onlay restorations will be fabricated using rubber dam scanning techniques and evaluated clinically up to 12 months

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: onlay preparation
Description: CAD-CAM onlay restorations will be fabricated using rubber dam scanning techniques and evaluated clinically up to 12 months
Study: NCT05051670

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: da vinc SP gastrectomy
Description: radical subtotal gastrectomy performed by da vinci SP